Pitching Endpoints News China Reporters: Vertical Press Strategy
Endpoints News is a must-win outlet for biotech and pharma news. Its China beat rewards sources who bring regulatory detail, deal context, and on-the-ground color—not press-release spin.
This guide gives you a repeatable playbook for earning coverage from a small, high-signal editorial team.
Editorial Scope: What Endpoints News Covers in China#
Endpoints tracks the business of drug development. On the China beat, that means licensing deals, cross-border partnerships, clinical data readouts, and regulatory shifts from NMPA and CDE.
Expect appetite for stories on biotech financing, IPO activity, manufacturing capacity, and US-China policy friction affecting pharma supply chains.
💡 Vertical Pro Tip: Lead with the business implication—deal value, market access, or pipeline impact. Endpoints readers are investors, BD executives, and policy watchers, not general consumers.
Identifying Active Writers on the Endpoints News China Reporters List#
The China beat is lean—often one or a few active writers covering a vast market. Kathy Wong is a representative name in our directory of Endpoints News China reporters.
Because staffing is small, one journalist may cover China, Asia-Pacific, and breaking global biotech news in the same week. Pitch accordingly: concise, timely, and easy to slot into a busy calendar.
A maintained Endpoints News China reporters list helps you track bylines, beat shifts, and recent story themes before you send anything.
Angles & Data Points That Resonate With Endpoints News China Journalists#
Endpoints News China journalists respond to exclusivity and specificity. A first look at a licensing term sheet beats a generic "company announces partnership" release every time.
Back your pitch with hard numbers: trial phase and enrollment, deal upfront and milestone figures, approval timelines, and pricing signals.
| Factor | Recommended Strategy | What Gets Ignored |
|---|---|---|
| News hook | Exclusive data, filings, or deal terms | Rewritten press releases |
| Timing | Same-day or embargoed advance access | Week-old announcements |
| Context | US-China policy or market-access angle | Company boilerplate |
| Sources | Named executives plus independent analysts | Marketing contacts only |
| Format | 3-4 sentence pitch with linked data | Attachments and long decks |
Best-fit story types:
- Cross-border licensing and co-development deals
- NMPA/CDE regulatory decisions and policy changes
- Clinical trial data from China-based sponsors
- Biotech financing, IPOs, and manufacturing expansion
Outreach Protocols & Accessing Endpoints News China Journalists Contacts#
Email remains the default channel. Keep subject lines factual and specific—"Exclusive: [Company] NMPA filing details" outperforms clever wordplay.
For Endpoints News China journalists contacts, verify the current byline and beat before pitching. A short, personalized opener referencing their last China story signals you did the work.
Respect embargoes precisely and offer data on request rather than upfront. Journalists at lean outlets value sources who make verification fast.
💡 Vertical Pro Tip: Build a lightweight tracker of Endpoints News China reporters—beat, recent stories, preferred contact—and refresh it quarterly. Small teams rotate beats often.
Fast-Action Pitch Checklist for China#
- Confirm the writer: Check the latest byline and beat focus.
- Sharpen the hook: One sentence on why this matters now.
- Add hard data: Deal figures, trial phases, approval dates.
- Offer exclusivity: First look or advance embargo access.
- Provide a named source: Executive or analyst available for comment.
- Link, don't attach: Keep the first email under 150 words.
- Follow up once: After 48-72 hours, then move on.
Pitching the China beat at Endpoints rewards precision over volume. Treat each send as a signal to a small, expert audience—and your hit rate will follow.